News At Ernest Pharma

Publications

Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases

October 21st, 2021 - Nature Communications

Intracellular Salmonella delivery of an exogenous immunization antigen refocuses CD8 T cells against cancer cells, eliminates pancreatic tumors and forms antitumor immunity

October 5th, 2023 - Frontiers in immunology

Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies

October 11th, 2023

Intracellular delivery of oncolytic viruses with engineered Salmonella causes viral replication and cell death

June 21st, 2024

Awards

NSF Phase I SBIR (1819794) and Phase II SBIR (2035560)

NIH Phase I SBIR 1R43CA233136-01, NIH Phase I SBIR 1R43CA250941-01A1

Massachusetts Life Science Center MassNextGen Award 2020

IALS/Manning award Umass Amherst 2019, 2020, 2023

Western Massachusetts Health Technology Challenge 2024 - 1st Place

Fellowships and Accelerators

MassConnect 2019

MassNextGen 2020 - Nele Van Dessel

Springboard 2022 - Nele Van Dessel

Termeer Fellowship 2023 - Nele Van Dessel